Revenue Cycle Management

Reimbursement should be a forethought, planned
during assay validation.

Does your institution need help navigating the reimbursement landscape of your NGS project?

Guarantee Financial & Clinical Success

icon_revenue-cycle-mgmt

Reimbursement strategy based on region & assay

icon_growth

Planning for Medicare coverage by region

icon_flexibility

MolDx dossiers & tech assessment support

icon_inferencing rules

Assay launch preparation support

icon_diversity

Expert consultation every step of the way

Plan Reimbursement Before Launching Your Program

Stocksy_txpd57aef59hsJ300_OriginalDelivery_3311495

Expert Consultation

  • Medicare MAC/Payer Mix Analysis
  • Review & Optimize Prior Authorization Workflow
  • Payor Templates: Pre-authorizations, appeals by level, letter of medical necessity
  • Expert Consultation: ICD-10 coding options & CLFS Coding Options by Assay
  • Up to 150 hours of total project support
Stocksy_txpd57aef59hsJ300_OriginalDelivery_968308

Collaboration on MolDx Packages & Market Access Dossiers

  • Analytical Validity, Clinical Validation Summary for NGS Solid Tumors or Myeloid Malignancies or Hereditary Germline testing cancer panels
  • Technical Assessment Submission Checklist and Questionnaire
  • Validation Sample Level Data Spreadsheet Master List
Stocksy_txpdf969153a0K300_OriginalDelivery_1083655

Assay Launch Preparation Support

  • Assay Overview, Description & Summary Creation by Assay
  • Patient Financial Assistance Program Review
  • Sub Panels/Disease Specific Tests Review
  • IT/RCM Integration Overview
  • Payor Contracting Review
  • Pricing Review

As NGS-based testing grows, NGS coverage and payment become critical drivers of adoption. 

Clinical Genomics Workspace
Advanced interpretation technology and clinical reporting
Genomic Knowledgebase
Advanced interpretation technology and clinical reporting
Professional Services
Advanced interpretation technology and clinical reporting